|
DBVT
|
DBV Technologies S.A.
|
US
|
NASDAQ
|
|
OCUL
|
Ocular Therapeutix, Inc.
|
US
|
NASDAQ
|
|
REVB
|
Revelation Biosciences, Inc.
|
US
|
NASDAQ
|
|
SPRY
|
ARS Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AGYTF
|
Allergy Therapeutics
|
US
|
OTC
|
|
AKBLF
|
ALK-Abelló A/S
|
US
|
OTC
|
|
ATMS
|
Artemis Therapeutics Inc.
|
US
|
OTC
|
|
INLB
|
Item 9 Labs Corp
|
US
|
OTC
|
|
MEDXF
|
Medexus Pharmaceuticals Inc
|
US
|
OTC
|
|
NPNKF
|
Nippon Shinyaku Co. Ltd
|
US
|
OTC
|
|
AGY
|
Allergy Therapeutics Plc
|
UK
|
LSE
|
|
ALK-B
|
ALK-Abelló A/S
|
DK
|
CO
|
|
SENZA
|
SenzaGen AB
|
SE
|
ST
|
|
MARI
|
Marinomed Biotech AG
|
AT
|
VI
|
|
4AJ0
|
ALK-ABELLO AS DK -50
|
DE
|
F
|
|
93Z
|
MARINOMED BIOTECH AG INH.
|
DE
|
F
|
|
HHU
|
ALLERGY THER. PLC LS-001
|
DE
|
F
|
|
CMH
|
Chordate Medical Holding AB
|
SE
|
ST
|
|
JUBLPHARMA
|
Jubilant Pharmova Limited
|
IN
|
NSE
|
|
0OIR
|
ALK-Abello B
|
GB
|
LSE
|